Format

Send to

Choose Destination
J Am Coll Cardiol. 2019 Jun 25;73(24):3135-3147. doi: 10.1016/j.jacc.2019.04.036.

Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement: JACC International.

Author information

1
Beijing Anzhen Hospital, Capital Medical University, Beijing, China; Heart Health Research Center, Beijing, China; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
2
The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
3
Heart Health Research Center, Beijing, China; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia; The George Institute for Global Health China at Peking University Health Science Center, Beijing, China.
4
Beijing Anzhen Hospital, Capital Medical University, Beijing, China; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
5
Beijing Anzhen Hospital, Capital Medical University, Beijing, China. Electronic address: chshma@vip.sina.com.

Abstract

The burden of cardiovascular (CV) disease is very high in China, due to highly prevalent and poorly controlled risk factors resulting from changing sociodemographic structure and lifestyles in its large population. Rapid economic development and urbanization have been accompanied by changing patterns, expression, and management of CV disease. However, the health care system in China lacks a hierarchical structure, with a focus on treating acute diseases in hospital while ignoring long-term management, and primary health care is too weak to effectively control CV risk factors. To address these challenges, the Chinese central government has ensured health is a national priority and has introduced reforms that include implementing policies for a healthy environment, strengthening primary care, and improving affordability and accessibility within the health system. Turning the inverted pyramid of the health care system is essential in the ongoing battle against CV disease.

KEYWORDS:

China; cardiovascular disease; chronic disease burden; quality of care

PMID:
31221263
DOI:
10.1016/j.jacc.2019.04.036

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center